Searched for
SPARC RALLY
Sun Pharma Advanced Research jumps 11%, extends 2-day rally as US court clears Sezaby PRVSun Pharma Advanced Research Company surged for a second straight session after a U.S. court ruled in its favour on the Sezaby Priority Rev...- What to do with Kotak Bank, Cochin Shipyard and 4 other stocks? Aamar Deo of Angel One decodesAamar Deo Singh advises caution in the volatile market amid global cues and US economic scenarios. Investors should focus on Nifty, Bank Ni...
- Breakout Stocks: Trade setup for The New India Assurance, General Insurance and SPARC which hit 52-week highsStocks that were in focus include names like The New India Assurance Company rose 20%, General Insurance Corporation gained more than 16% a...
- Big Movers on D-St: What should investors do with SPARC, Delta Corp and M&M?The short-term texture of the stock is weak but it is trading in an oversold zone. We are of the view that as long as it is trading below R...
- After Market: YES Bank stages solid bounce; auto sees value buying; Airtel, RIL big winnersRIL and TCS were the biggest contributors to the 115.35 point gain in the 30-share Sensex.
- After Market: SPARC rallies 5%; PCJ, YES Bank sink; 57 stocks turn oversoldNifty Midcap index shed 1.28% to 16,512 while Nifty Smallcap index dipped 1.13% to 5,590.
- Mapping the market: Data war hits telcos hard; royalty burden spooks OIL, ONGCAll in all, it was a stock-specific session where Sensex fell 90 points to 27,746, while Nifty50 barely managed to hold above the 8,500 mar...
- Pharma companies set to gain, but be selective in the stocks you buyExperts believe the story in the pharma space is not yet over and investors are looking into the space not only from a defensive point of v...
- Tata Elxsi, SPARC, Emami and Natco Pharma surge on reports of F&O inclusionShares of some of these companies have rallied 50% to 190% this year so far. Analysts say markets are in an uptrend.
- Tata Elxsi, Emami, Natco Pharma may join F&O listShares of some of these companies have rallied 50% to 190% this year so far. More stocks are qualifying for inclusion in the F&O segment.
- Sun Pharma Advanced Research Company shares surge 15 per cent; m-cap up by Rs 1,685 croreStocks of Sun Pharma Advanced Research Company Ltd surged 15 per cent today after the company received approval from the US health regulato...
- Further upside likely in Sun Pharma, stk can hit Rs 1,150: Mitesh ThackerThacker said that Rs 1,100 could be a good short-term target for Sun Pharma. Eventually, this stock can top Rs 1,150, he believes.
- Earnings, ANDA approvals to supplement pharma stocks: Neeraj Deewan, Quantum SecuritiesA continuous improvement in earnings on sequential basis will continue and pharma stocks may keep on performing well, believes Quantum Secu...
- Sun Pharma has potential to gain another 15-20%: Mayuresh Joshi, Angel BrokingJoshi points out that after the merger with Ranbaxy, the drug maker will cover all the niche area, all possible segments of the generic mar...
- Markets trying to come out of the woods: Ashwani GujralAs we go into the close, you have all kinds of financial like Can Fin Home, Chola Finance, Edelweiss, everything is doing well and hence th...
- Market on the cusp of a pre-Budget rally: Ambareesh BaligaI hope that this liquidity, sentiment-driven rally does not become a bubble, Baliga said. He hopes that the fundamentals actually catch up.
- SPARC rallies over 14% on receiving CRL from USFDA for Latanoprost NDASun Pharma Advanced Research Company Ltd (SPARC) rallied as much as 14.2 per cent in intraday trade on Monday.
- Buy SPARC for Rs 110 target: Ashwani GujralFor SPARC, Rs 107 to Rs 110 is a fairly strong resistance. So, that is your target No. 1. In case that is crossed, then you have probably b...
- Watch out for ICICI Bank, SBI next week : Technical TrendsMy selection for next week I told you about ICICI Bank, may be TCS and certainly SBI.
- Airline stocks benefiting from rally: Deepak MohoniAll of the three main ones ones are going up pretty sharply.
Load More
